Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the anti-cancer effect of a pain medication called
ketorolac (Toradol) on ovarian cancer cells in the abdominal (peritoneal) cavity after
surgery for ovarian, fallopian tube or primary peritoneal cancer.